Hong Kong Pharma Digital Technology Holdings Ltd. (HKPD)
NASDAQ:HKPD
HKPD Stock Chart & Stats
$0.73
--
Market closed
$0.73
--
Day’s Range― - ―
52-Week Range$0.32 - $2.58
Previous CloseN/A
VolumeN/A
Average Volume (3M)272.13K
Market Cap
$3.96M
Enterprise Value$6.13M
Total Cash (Recent Filing)$3.01M
Total Debt (Recent Filing)$2.37M
Price to Earnings (P/E)―
Beta1.10
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding11,000,000
10 Day Avg. Volume84,112
30 Day Avg. Volume272,130
Financial Highlights & Ratios
PEG Ratio3.94
Price to Book (P/B)1.95
Price to Sales (P/S)0.48
P/FCF Ratio23.52
Enterprise Value/Market Cap1.55
Enterprise Value/Revenue0.30
Enterprise Value/Gross Profit2.54
Enterprise Value/Ebitda23.06
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Hong Kong Pharma Digital Technology Holdings Ltd. News
HKPD FAQ
What was Hong Kong Pharma Digital Technology Holdings Ltd.’s price range in the past 12 months?
Hong Kong Pharma Digital Technology Holdings Ltd. lowest stock price was $0.32 and its highest was $2.58 in the past 12 months.
What is Hong Kong Pharma Digital Technology Holdings Ltd.’s market cap?
Hong Kong Pharma Digital Technology Holdings Ltd.’s market cap is $3.96M.
When is Hong Kong Pharma Digital Technology Holdings Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Hong Kong Pharma Digital Technology Holdings Ltd.’s earnings last quarter?
Currently, no data Available
Is Hong Kong Pharma Digital Technology Holdings Ltd. overvalued?
According to Wall Street analysts Hong Kong Pharma Digital Technology Holdings Ltd.’s price is currently Overvalued.
Does Hong Kong Pharma Digital Technology Holdings Ltd. pay dividends?
Hong Kong Pharma Digital Technology Holdings Ltd. does not currently pay dividends.
What is Hong Kong Pharma Digital Technology Holdings Ltd.’s EPS estimate?
Hong Kong Pharma Digital Technology Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hong Kong Pharma Digital Technology Holdings Ltd. have?
Hong Kong Pharma Digital Technology Holdings Ltd. has 11,000,000 shares outstanding.
What happened to Hong Kong Pharma Digital Technology Holdings Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Hong Kong Pharma Digital Technology Holdings Ltd.?
Currently, no hedge funds are holding shares in HKPD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Hong Kong Pharma Digital Technology Holdings Ltd.
Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the international sourcing and distribution of OTC medications, alongside comprehensive e-commerce supply chain management. Furthermore, it provides essential logistical support, including customs clearance, drug registration, and warehousing facilities. Cellyan Biotechnology caters to a diverse clientele, which includes logistics partners for e-commerce platforms, various merchants, and pharmaceutical distributors. Founded in 2023, the company is based in Yau Tong, Hong Kong. It was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and officially adopted the name Cellyan Biotechnology Co., Ltd in December 2025.
Technical Analysis
Singularity Future Technology
―
Addentax Group
―
PS International Group
―
Globavend Holdings Ltd.
―
New Century Logistics (BVI) Ltd.
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.47% Other Institutional Investors
99.53% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---